INMB May 2024 20.000 call
| Previous close | 0.1000 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 5.0000 |
| Strike | 20.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.1000 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 14 |
Insider MonkeyINmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript
INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript May 11, 2024 INmune Bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the INmune Bio First Quarter 2024 Earnings Call. At the end of the […]
Simply Wall St.INmune Bio First Quarter 2024 Earnings: EPS Misses Expectations
INmune Bio ( NASDAQ:INMB ) First Quarter 2024 Results Key Financial Results Net loss: US$11.0m (loss widened by 69...
GlobeNewswireINmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
Company to Host Conference Call Today, May 9, at 4:30pm ETBOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial results for the quarter ended March 31, 2024 and provides a business update. Q1 2024 and Recent Corporate Highlights DN-TNF Platform Highlights (XPro™): The AD02 randomized, blin
